French biopharmaceutical firm wants to raise at least $31 million.
|
Red Herring magazine’s finance news briefs for the week of June 5, 2006.
|
But the Deutsche Börse is challenging the deal to combine the New York and Europe exchanges.
|
Red Herring magazine’s bioscience news briefs for the week of May 29, 2006.
|
Amsterdam-based exchange may merge with New York in $10.2-billion deal, but is still considering Deutsche Börse’s offer.
|
French biotech firm, a Red Herring 100 company, will list on Euronext exchange.
|
France’s Emailvision hopes to double its European market share.
|